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Selected glucocorticoids have been demonstrated to 
increase the growth rate of human skin fibroblasts in 
culture, over a physiologically significant concentration 
range. 
At the same concentrations and identical conditions, 
the glucocorticoid compounds tested inhibited the 
growth rate of mouse L-929 cells. We have discussed 
currently acceptable theories of glucocorticoid mecha-
nism of action that permit this dichotomous effect, the 
main point being that inhibition can no longer be re-
garded as the only response of fibroblasts to glucocorti-
coids. Conclusions drawn from observations of cell cul-
tures affected by addition of glucocorticoids must have 
considered the source of the cells, as response may vary 
with source and biologic state of the cells in culture. 
Glucocorticoids, structured for topical use, when added to 
mouse L-929 cell cultures inhibit their proliferation [1-3]. This 
formed the basis for a parallel line assay that predicted gluco-
corticoid clinical anti-inflammatory activity better than rat 
granuloma and thymus involution assays [ 4,5]. The cells have 
been subsequently utilized for other studies of glucocorticoid 
receptors [1 ,6], and contributed to the development of a unitary 
protein synthesis theory for glucocorticoid mechanism of action 
[3]. The assay is still highly regarded as a means for determi-
nation of glucocorticoid potency [7,8] and its recognized inhib-
itory effect is often quoted to account for the striae, skin 
thinning and telangiectasia observed from clinical applications 
of topical glucocorticoids. 
Doubts, however, have been expressed of the applicability of 
the assay to the human situation. Winter and Wilson [9] found 
that the mouse fibroblast assay correlates neither with the 
vasoconstriction assay, nor with the atrophic skin thinning 
effect on the epidermis of the pig, nor with the clinical topical 
activity for fluocinolone acetonide, triamcinolone acetonide, 
and betamethasone valerate (paradoxically the weakest by 
fibroblast assay) series. 
Another consideration is the outdated theoretical basis of the 
mouse fibroblast assay. The originators of the assay described 
transformation of fibroblasts to a rounded shape, reduced met-
abolic activity and growth rate, inhibition of new collagen 
formation and dissolution of already formed collagen as direct 
effects of glucocorticoids [ 4]. This correlated with the view 
originally proposed by Albright [10] that all extrahepatic cells, 
regardless of their genetic history are subject to antianabolic 
inhibitory glucocort icoid influence [3]. However, a great deal of 
accumulating evidence shows that glucocorticoids can increase 
proliferation in cell cultures of diverse origin, among them 
human cell cultures [11,12]. In addition to glucocorticoid pro-
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duction of increased growth rates [13], increased formation of 
DNA [14), RNA [15], proteins and other macromolecules [12] 
as glucocorticoid effects have been confirmed. 
Kirk and Mittwoch [16) have found that fluocinolone aceto-
nide and hydrocortisone had a transient stimulatory effect on 
human fetal skin fibroblasts promoting an early entry and 
lengthening in the DNA synthesis (S) phase of the cells. Cell 
growth rate was slightly increased. There were no inhibitory 
effects noted. 
These observations agree with the current concepts of pri-
mary glucocorticoid mechanism of action which is one of mRN A 
and protein synthesis stimulation [17,18]. 
The often quoted parallel [3,4,5,19-22] between the anti-
inflammatory and atrophic effects of topical glucocorticoids, 
and their inhibition of mouse L-929 fibroblasts in rapid growth 
phases, may be fortuitous. It is perturbing to find such an 
authority on the fibroblast as Leonard Hayflick [23] questioning 
the relevance of biological data obtained from studies of abnor-
mal cell lines such as 3T3, BHK 21 and mouse L cells "which 
resemble no in vivo cell type." 
We addressed ourselves therefore to comparing the effect of 
hydrocortisone, triamcinolone acetonide, desonide, and beclo-
methasone dipropionate on mouse L-929 and human adult 
diploid fibroblasts closely following the original Berliner and 
Ruhmann [ 4) and Brotherton [5] assay conditions which used 
only the L-929 fibroblasts. 
MATERIALS AND METHODS 
Five cell lines were used: mouse fibroblast NCTC clone L-929, ATCC 
No. CCL-1 (Flow Laboratories, Inglewood, California); human skin 
fibroblast ATCC No. CRL-1104 BiRil, male, 29 yr (American Type 
Culture Collection, Rockville, Maryland) ; human skin fibroblasts, 
Peggy ·and Ruth, females, 25 and 29 yr; and human skin fibrob last, 
Bruce, male 29 yr (courtesy Dr. H. Stich, Cancer Research Centre, 
University of British Columbia, Vancouver, Canada). The cells were 
maintained as a monolayer on 100 X 20 mm tissue culture places in 
Dulbecco's Modified Eagle Medium (MEM) with L-glutamine (Gibco) , 
containing 3.7 gm sodium bicarbonate/liter medium, 15% fetal calf 
serum (Flow), gentamicin (Gentamycin, Gibco) 40 J.lg/ ml medium, and 
amphotericin B (Fungizone, Gibco), 1.25 J.lg/ml medium. In later exper-
iments, gentamicin was t·eplaced by penicillin and streptomycin (100 
J.lg / ml). The cells were incubated at 37° in 5% C02, 95% air. All human 
cells used were less than 12th passage. T he mouse cells have been 
maintained by Flow Laboratories for many years. There have been 
reports indicating that the metabolic activity of mouse cell culture lines 
may be decreasing with the passage of years [24). 
Solutions in a propylene glycol vehicle were prepared from hydro-
cortisone (Glaxo, Toronto, Ontario) , desonide (Dome, Toronto, On-
tru·io), triamcinolone acetonide (Squibb, Montreal, Quebec) and beclo-
methasone dipropionate (Glaxo), using the method of Brotherton [5]. 
Control solu tions using the propylene glycol vehicle alone were also 
prepared. Handling of steroid and control solut ions was identical. 
In the assay procedure, 50,000 mouse or 100,000 human fibroblasts 
were transferred in 5 ml of medium to a 60 x 15 mm tissue culture 
plate (Falcon) on Day 0. The medium was exchanged for a fresh one 
containing glucocorticoids on Day 1, allowing cells to adhere as well as 
to enter log growth phase. The cells were counted on Day 4. 
The fibroblasts were harvested with the aid of trypsinization (0.25% 
trypsin without calcium and magnesium in Hank's BSS, Flow), scraping 
with a rubber policeman, vigorous pipetting, and counting on a Coulter 
Counter, Model B. The contact time of the trypsin solution with mouse 
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f ibroblast cells was 1 min, with human fibroblasts, 5 min. Cell separation 
b y vigorous pipetting alone or with the aid of DNAse in place of 
try psinization was tried, but in our hands was inferior. Brotherto.n [5] 
s tates trypsinization is contraindicated for L-929 cells. In our expenence 
1 minute's trypsinization for mouse cells and 5 min for human cells, 
together with careful scraping with a rubber policeman, gives the most 
r e producible results . Berliner used trypsinization. 
RESULTS 
All glucocorticoids tested demonstrated a clear inhibition of 
mouse L-929 fibroblasts. Equally clearly, they stimulated 
growth rates 0f human skin fibroblasts derived from 5 different 
cell lines under identical media and logarithmic growth rate 
conditions. For human fibroblasts (100,000 inoculum, 60-mm 
plates), cell population increase during the 4-day growth period 
reached between 200,000 to 400,000. For mouse fibroblasts 
(50,000 inoculum, 60-mm plates), cell population increase dw--
ing the 4-day growth period reached between 500,000 to 1,-
500,000. Such 2- to 3-fold variations have been experienced and 
exceeded by other workers [5,19]- Relative inhibition or stim-
ulation therefore, is expressed in terms of percent of means of 
siinultaneous controls ± .the largest coefficient of vru·iation 
encountered among repeat experiments (Table) . The coefficient 
of variation is the standard deviation expressed as the percent 
of the mean cell counts observed in one run. (Two to 4 duplicate 
plates were used to test the effect of a selected glucocorticoid 
concentration in each experiment). Compru-isons by t-test 
showed that cell population increases (or decreases) under the 
influence of glucocorticoids which were greater than 10% of 
controls were significant at the P <0.01 or less. Therefore, cell 
population differences larger than 10% were considered large 
enough for the detection of inhibitory or stimulatory effect and 
are shown outside the control range (Fig 1). 
Growth stimulation of human skin fibroblasts and growth 
inhibition of mouse cells for all glucocorticoids were concentra-
tion dependent as shown for triruncinolone in the Table. Figure 
1 and the Table are representative of cell counts after 3 days of 
glucocorticoid addition (4 days after subculture). Trial experi-
ments determining numbers of cells 4 and 10 days after gluco-
corticoid addition showed that both stimulation and inhibition 
were even more pronounced, although by Day 10, both mouse 
and human cells had grown to confluence. 
Berliner and Ruhmann [ 4] demonstrated triruncinolone ace-
tonide to be 156 times more potent than hydrocortisone from 
their effects on mouse L-929 cells. Ow- dose-response curves of 
these steroids correspond (Fig 2) . The dose-response curves for 
desonide and beclomethasone dipropionate fall between these 
2 reference steroids, indicating lower potency than triamcino-
lone acetonide, but greater than hydrocortisone, as expected 
from clinical data. For the purposes of this paper, however, we 
claim no exact determination of relative potency values. 
The growth response of the cell populations changed rapidly 
with small increases in glucocorticoid concentration (Fig 1). 
Logarithmic number of cells vs glucocorticoid concentration 
plots becrune approximately linear over this limited concentra-
tion range, which started at a lower concentration for more 
potent glucocorticoids, in agreement with the previous investi-
gations of mouse L-929 fibroblasts reported [ 4,5]- Figure 2 
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0 Mouse L-929, n = 18 
• Human Bruce, n = 4 
.. Human Peggy, n = 10 




Hydrocortisone (fJg / ml) 
Ftc 1. The effect of increasing concentrations of hydrocort isone in 
inhibiting growth of mouse L929 cells, and stimulating growth of 3 
human cell lines. 








-• Hydrocortisone, n = 18 
·- _,. De son ide n, = 10 
-- -.:. Triamcinolone Acetanide, n = 10 
Glucocorticoid (}Jg/ml) 
FIG 2. The effect of increasing concen trations of 3 differen t gluco-
corticoids in inhibiting the growth rate of mouse L929 cells. 
Triamcinolone acetonide effect on mouse and human fibroblast growth 
Cell strain and number of observations (n) 
11g steroid/ rnl medium 
Mouse L-929 (n) Human P eggy (n) Human BiRil (n) Human Bruce (n) 
0.00001 93 ± 7" (12) 122 ± 2 (4) 111±4 (4) 
0.0001 89 ± 6 (12) 121 ± 4 (4) 112 ± 5 (4) 
0.001 75 ± 6 (10) 149 ± 1 (10) 125 ± 5 (6) 136 ± 5 (4) 
0.01 68 ± 9 (6) 150 ± 5 (10) 124 ± 8 (4) 132 ± 4 (4) 
0.1 51± 8 (10) 158 ± 3 (10) 130 ± 8 (6) 130 ± 4 (4) 
1.0 47 ± 9 (4) 140 ± 4 (6) 113±5 (4) 115 ±6 (2) 
" Mean as % of control ± largest coefficient of variat ion within series . Note: For brevity, the values for triamcinolone acetonide only are shown. 
Comparable values were obtained with hydrocortisone, desonide and beclomethasone dipropionate. (Fig 2). 
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graphically shows 38 observations of mouse cells 3 days after 
addition of 3 selected glucocorticoids. Beclomethasone dipro-
pionate produced similar inhibition effects, but was not added 
to this figure to avoid a confusing clustering of observation 
points. 
The topical steroids more potent than hydrocortisone by 
vasoconstriction assay produced more pronounced suppression 
at lower concentration than the reference glucocorticoid. This 
growth inhibitory effect continued up to the highest concentra-
tion investigated (10 1-Lg/ rnl). At this concentration, hydrocor-
t isone plates showed approximately 70% and the more active 
glucocorticoids 45% of the cell population of their respective 
controls. 
Growth inhibition of mouse cells continued to increase with 
increasing glucocorticoid concentration, while human fibroblast 
stimulation reached a peak for all tested glucocorticoids at the 
level of 150-160% over controls. The peak concentration varied 
with glucocorticoid potency, stronger steroids reaching their 
peak effect as low as 0.001 1-Lg/ rnl, the weaker hydrocortisone 
reaching it at higher concentrations of 0.1-1.0 1-Lg/ rnl. The 
precise concentration of each steroid's maximum stimulatory 
effect was not sought. Human fibroblasts appeared by their 
growth response to discriminate less clearly between chemical 
structure differences than mouse fibroblasts did. The human 
fibroblast response in this respect correlates with the clinical 
experience which allows recognition of a change in concentra-
tion of the potent steroids only by a factor of 10-40 as compared 
with hydrocortisone (0.25%-0.01% for triamcinolone acetonide 
vs 0.5%-1.0% for hydrocortisone). For comparative purposes, it 
may be noted that the physiological hydrocortisone concentra-
t ion in plasma is commonly regarded to be 0.04-0.2 1-Lg/ rnl. 
DISCUSSION 
The results demonstrate that a physiologically significant 
concentration range exists in which all glucocorticoids tested 
are able to stimulate the growth rate of human skin fibroblasts 
in culture. Under the same conditions and glucocorticoid con-
centrations, mouse L-929 cell growth rates are inhibited. 
Stimulation of human cell growth by glucocorticoids has. 
again been observed previously [12,14,25), and in the case of 1 
compound (hydroxymethylprednisolone) tested by Ruhmann 
and Berliner [21], growth stimulation of mouse L-929 cells 
occurred. 
Berliner and Ruhmann [19] related the glucocorticoid inhi-
bition of mouse L-929 cell growth rates to steroid anti-inflam-
matory activity and Berliner, Panagiotis, and Nabors [26) re-
lated the reduced growth rates to decreased collagen content. 
Atrophy and other adverse clinical steroid effects were attrib-
uted to this process and the concept of fibroblast inhibition as 
a cause of these undesirable effects has dominated clinical 
concepts for 25 yr. 
Our experiments as described on glucocorticoid effect on 
fibroblasts have revealed the dichotomous effects of mouse L-
929 cell growth inhibition and human fibroblast growth stimu-
lation. It must be pointed out that most tissue culture work has 
been done on cultures in a stationary confluent phase with 
transformed cell lines which lack many of the responses to 
growth control effectors operative in vivo. This renders them 
poor models in the study of physiologically significant growth 
control mechanisms. This may be one of the reasons why the 
glucocorticoid growth rate stimulating effect on cells in log 
growth phase that we observed, has not yet been reported. Now 
that the techniques of growing human skin fibroblasts have 
become more widely available, we find confrrming evidence in 
the work of other investigators [12]. Cunningham, Thrash, and 
Glynn [13] experimented with mouse 3T3, L-929, malignant 
Py3T3, malignant SV3T3 and human foreskin fibroblasts. They 
found that hydrocortisone stimulated both the growth rates 
and DNA synthesis of the 3T3 and human foreskin fibroblasts, 
but not the L-929 and the malignant cells. They considered that 
the following 3 points should be considered to account for the 
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observed differences between the L-929 and the human fibro-
blast responses to glucocorticoids. (1) Stimulation by cortisol 
might require higher levels of serum than were employed in the 
experiments (10%) because stimulation might depend on prior 
binding of hydrocortisone to a serum protein such as transcor-
tin. This can be hardly likely because we did use a higher serum 
concentration (15%) and triamcinolone acetonide does not bind 
to transcortin. (2) Hydrocortisone might initiate DNA synthesis 
only in the Go phase of the cell cycle. An equivalent rest phase 
may not exist in such cultures in order to compare these 
unnatural cells with normal ones. (3) Intracellular cell compo-
nents, e.g., cytosol glucocorticoid receptors may have been 
altered and become unresponsive. This is unlikely because they 
respond to glucocorticoids by growth inhibition. 
Kirk and Mittwoch [16], in discussing their results, empha-
sized the biphasic nature of the cellular response to glucocorti-
coids and their role as homeostatic growth regulators possessing 
both enhancing and inhibitory properties. 
The mechanisms which cause topical glucocorticoids to stin1-
ulate the growth rates of human skin fibroblasts but to inhibit 
mouse L-929 skin fibroblasts are unknown. It has been sug-
gested by Tomkins that the glucocorticoid effect on L-929 or 
similar transformed cells may be due to a lack of a pleiotypic 
mediator in these cells, as appears to be the case in malignant 
cells [27]. According to Tomkins, all cells under unfavourable 
growth conditions such as absence of serum, are locked into a 
rest phase by a membrane-located negative regulator, the 
"pleiotypic mediator," probably a nucleotide. Transformed cell 
lines, such as the L-929's may lack this regulator. One effect of 
serum, glucocorticoids, or insulin, all of which stimulate cell 
proliferation, could be the displacement of "the pleiotypic me-
diator" from cell membrane. Displacement of this mediator is 
then followed by a series of metabolic stimulating effects, among 
them RNA synthesis, protein synthesis, polysome formation, 
nucleic acid precw·sor uptake and glucose uptake which would 
explain the observed growth rate stimulation. Such a stimulat-
ing effect, according to this theory, would be observed in early 
passage human skin fibroblasts, but not the L-929 cells. 
The growth response shown by human skin fibroblasts to the 
administration of glucocorticoids thus may be a net result 
between glucocorticoid inhibitory activity and pleiotypic stim-
ulatory activity. In the L-929 cells we would see only the 
inhibitory effect. This reasoning could explain the limited 
growth stimulation observed which was approximately the 
same for all glucocorticoids tested, and would also explain the 
unlimited inhibitory effect we observed on the L-929 cells. 
These cells continued to show increasing growth inlllbition up 
to the highest concentrations used (10 1-Lg/rnl) for all glucocor-
ticoids tested. No pleiotypic mediator has yet been identified, 
however. 
The results of these experiments, as do those of Kirk and 
Mittwoch [16] indicate very clearly that it is unwise to accept 
without qualification, data obtained from studies that use het-
eroploid or genetically abnormal cell lines to evaluate patencies 
of topical glucocorticoids or to extrapolate those data to explain 
glucocorticoid effects in man. It is also apparent that general-
izations of glucocorticoid mechanisms of action which assume 
a universal inhibitory effect on peripheral cells are misleading. 
Finally, as fibroblasts have many and varied functions, no 
generalization can be utilized to explain glucocorticoid effect on 
these cells. 
Glucocorticoids were supplied by Dome Laboratories (desonide) , 
Glaxo (beclomethasone dipropionate and hydrocortisone), and E. R. 
Squibb & Sons Ltd. (Triamcinolone acetonide) . 
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